MTMohammed Tikly

Mohammed Tikly

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mohammed Tikly has a total of 122 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical and Serological Correlates of Serum C1Q and Anti‐C1Q Antibodies in South Africans With Systemic Lupus Erythematosus

    by Mohammed Tikly, Lillemor Skattum, Mohamed Amin Makda

    Objective: To investigate prevalence and clinical correlates of serum C1q and anti‐C1q antibody titres in black South Africans with systemic lupus erythematosus (SLE).Methods: Cross‐sectional study of 96 SLE patients, 49 with lupus nephritis (LN). Anti‐C1q antibodies were tested by ELISA. Serum C1q was measured as a percentage of normal by immunoelectrophoresis. Disease activity was assessed using the SELENA‐SLE disease activity index.Results: Most patients were female (90.7%), mean (SD) age and follow‐up period diagnosis of 38.1 (13.0) and 4.2 (4.4) years, respectively. Low serum C1q and positive anti‐C1q antibody test were detected in 17 (17.7%) and 12 (12.5%) patients, respectively, overall. There was an inverse correlation between serum C1q and anti‐C1q antibodies titres (r = −0.22, p = 0.03) and a direct correlation of anti‐C1q antibodies titres with SELENA‐SLEDAI scores (r = 0.27, p = 0.008). Patients with an active urine sediment (n = 21) had higher anti‐C1q antibodies titres (p = 0.007) and low serum C1q (OR = 4.51, p = 0.01), compared to the remainder of patients. Anti‐C1q antibody titres were higher in patients with C3/C4 hypocomplementaemia (n = 14) than those with normal C3/C4 (p = 0.02). A positive Coombs test (without evidence of red cell haemolysis) (n = 17) was associated with a positive anti‐C1q antibody test (OR = 4.29, p = 0.02), low serum C1q (OR = 3.37, p = 0.04) and C3/C4 hypocomplementaemia (OR = 4.84, p = 0.02).Conclusion: Our findings broadly confirm the clinical utility of the anti‐C1q antibody test in SLE. Raised anti‐C1q antibody titres were associated with active LN, as evidenced by an active urine sediment. The association of a positive anti‐C1q antibody and low serum C1q with a positive Direct Coombs' test merits further study and confirmation.

  • Open Access

    CLINICAL AND SEROLOGICAL CORRELATES OF SERUM C1Q AND ANTI-C1Q ANTIBODIES IN SOUTH AFRICANS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

    by Mohammed Tikly, Lillemor Melander Skattum, Mohamed Amin Makda

    OBJECTIVE: To investigate the prevalence and clinical correlates of serum C1q and anti-C1q antibody titres in black South Africans with systemic lupus erythematosus (SLE). METHODS: Cross-sectional study of 96 black South African SLE patients, 49 with lupus nephritis (LN). Anti-C1q antibodies were tested using an enzyme linked immunoassay. Serum C1q was measured as a percentage of normal by immunoelectrophoresis, using an in-house rabbit-anti-C1q antiserum. Disease activity was assessed using SELENA-SLE disease activity index. RESULTS: Most patients were female (90.7%), mean (SD) age and follow-up period diagnosis of 38.1(13.0) and 4.2 (4.4) years, respectively. Low serum C1q and positive anti-C1q antibody test were detected in 17 (17.7%) and 12 (12.5%) patients, respectively, overall. There was inverse correlation between serum C1q and anti-C1q antibodies titres (r=-0.22, p=0.03) and a direct correlation of anti-C1q antibodies titres with SELENA-SLEDAI scores (r=0.27, p=0.008). Patients with an active urine sediment (n=21) had higher anti-C1q antibodies titres (p=0.007) and low serum C1q (OR=4.51, p=0.01), compared to the remainder of patients. Anti-C1q antibody titres were higher in patients with C3/C4 hypocomplementaemia (n=14) than those with normal C3/C4 (p=0.02). A positive Coombs test (without evidence of red cell haemolysis) (n=17) was associated with a positive anti-C1q antibody test (OR=4.29, p=0.02), low serum C1q (OR=3.37, p=0.04), and C3/C4 hypocomplementaemia (OR=4.84, p=0.02). CONCLUSION: Our findings broadly confirm the clinical utility of anti-C1q antibody test in SLE, particularly as a biomarker of active LN, as evidenced by an active urine sediment. The association and clinical relevance of a Direct Coombs test with elevated anti-C1q antibodies and low C1q merits further study and confirmation.

  • Open Access

    The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis—Interstitial Lung Disease in the European Scleroderma Trial and Research Database

    by Gemma Lepri, Cosimo Bruni, Lorenzo Tofani, Alberto Moggi-Pignone, Martina Orlandi, Sara Tomassetti, Michael Hughes, Francesco Del Galdo, Rosaria Irace, Oliver Distler, et al.

    Background and Objectives: In SSc, ILD is a major cause of morbidity and mortality. We aimed to investigate the performance of DLCO (diffusing capacity of lung carbon monoxide) and FVC (forced vital capacity) delta change (Δ) and baseline values in predicting the development of SSc-ILD. Methods: Longitudinal data of DLCO, FVC, and ILD on the HRCT of SSc patients from the EUSTAR database were evaluated at baseline (t0) and after 12 (±4) (t1) and 24 (±4) (t2) months. Results: 474/17805 patients were eligible for the study (403 females); 46 (9.7%) developed ILD at t2. Positivity for anti-topoisomerase antibodies (117 patients) showed an association with ILD development at t2 (p = 0.0031). Neither the mean t0 to t1 change (Δ) of DLCO nor the mean t0 to t1 FVCΔ predicted the appearance of ILD at t2. Investigating the possible role of baseline DLCO and FVC values in predicting ILD appearance after 24 (±4) months, we observed a moderate predictive capability of t0 DLCO < 80%, stronger than that of FVC < 80%. Conclusions: We suggest that an impaired baseline DLCO may be predictive of the appearance of ILD after 2 years of follow-up. This result advances the hypothesis that a reduction in gas exchange may be considered an early sign of lung involvement. However, further rigorous studies are warranted to understand the predictive role of DLCO evaluation in the course of SSc.


  • Open Access

    Causes and predictors of mortality in South Africans with systemic sclerosis

    by Zodwa Dire, Claudia Ickinger, Mohammed Tikly

    Background: There is a dearth of mortality data on systemic sclerosis (SSc) in sub‐Saharan Africa. We undertook a retrospective study of causes and predictors of death in low‐income indigent South Africans with SSc.Methods: A retrospective records review of clinicodemographic, laboratory, and outcome data of SSc patients attending a state‐funded tertiary Rheumatology service in South Africa.Results: Most of the 164 patients were Black (92.7%) and female (87.8%). The mean (SD) age at diagnosis and follow‐up duration were 42.6 (12.9) and 5.5 (5.6) years, respectively. The majority (75.6%) had diffuse cutaneous SSc (dcSSc); and digital pits/ulcers, interstitial lung disease (ILD), and pulmonary hypertension (PH) were documented in 73.6%, 55.0%, and 38.3%, respectively. There were 56 known deaths and an equal number of patients were lost to follow‐up. Deaths resulted from ILD complicated by PH (42.9%), infections (8.9%), cardiac disease (7.1%), and malignancies (3.6%). Estimated 5‐ and 10‐year survival rates for patients with known outcomes were 58% and 42%, respectively. Independent predictors of death were renal dysfunction and cor pulmonale.Conclusion: Most patients in this study of South Africans had dcSSc and poor outcomes. Known deaths resulted from cardiorespiratory complications of ILD complicated by PH. Cor pulmonale and renal dysfunction were independent predictors of death.


  • A genome-wide association study for rheumatoid arthritis replicates previous HLA and non-HLA associations in a cohort from South Africa

    by Evans M Mathebula, Dhriti Sengupta, Nimmisha Govind, Vincent A Laufer, S Louis Bridges Jr, Mohammed Tikly, Michèle Ramsay, Ananyo Choudhury

    The complex pathogenesis of rheumatoid arthritis (RA) is not fully understood, with few studies exploring the genomic contribution to RA in patients from Africa. We report a genome-wide association study (GWAS) of South-Eastern Bantu-Speaking South Africans (SEBSSAs) with seropositive RA (n = 531) and population controls (n = 2653). Association testing was performed using PLINK (logistic regression assuming an additive model) with sex, age, smoking and the first three principal components as covariates. The strong association with the Human Leukocyte Antigen (HLA) region, indexed by rs602457 (near HLA-DRB1), was replicated. An additional independent signal in the HLA region represented by the lead SNP rs2523593 (near the HLA-B gene; Conditional P-value = 6.4 × 10−10) was detected. Although none of the non-HLA signals reached genome-wide significance (P < 5 × 10−8), 17 genomic regions showed suggestive association (P < 5 × 10−6). The GWAS replicated two known non-HLA associations with MMEL1 (rs2843401) and ANKRD55 (rs7731626) at a threshold of P < 5 × 10−3 providing, for the first time, evidence for replication of non-HLA signals for RA in sub-Saharan African populations. Meta-analysis with summary statistics from an African-American cohort (CLEAR study) replicated three additional non-HLA signals (rs11571302, rs2558210 and rs2422345 around KRT18P39-NPM1P33, CTLA4-ICOS and AL645568.1, respectively). Analysis based on genomic regions (200 kb windows) further replicated previously reported non-HLA signals around PADI4, CD28 and LIMK1. Although allele frequencies were overall strongly correlated between the SEBSSA and the CLEAR cohort, we observed some differences in effect size estimates for associated loci. The study highlights the need for conducting larger association studies across diverse African populations to inform precision medicine-based approaches for RA in Africa.


  • Open Access

    nf-rnaSeqCount: A Nextflow pipeline for obtaining raw read counts from RNA-seq data

    by Phelelani Mpangase, Jacqueline Frost, Mohammed Tikly, Michèle Ramsay, Scott Hazelhurst

    The rate of raw sequence production through Next-Generation Sequencing (NGS) has been growing exponentially due to improved technology and reduced costs. This has enabled researchers to answer many biological questions through “multi-omics” data analyses. Even though such data promises new insights into how biological systems function and understanding disease mechanisms, computational analyses performed on such large datasets comes with its challenges and potential pitfalls. The aim of this study was to develop a robust portable and reproducible bioinformatic pipeline for the automation of RNA sequencing (RNA-seq) data analyses. Using Nextflow as a workflow management system and Singularity for application containerisation, the nf-rnaSeqCount pipeline was developed for mapping raw RNA-seq reads to a reference genome and quantifying abundance of identified genomic features for differential gene expression analyses. The pipeline provides a quick and efficient way to obtain a matrix of read counts that can be used with tools such as DESeq2 and edgeR for differential expression analysis. Robust and flexible bioinformatic and computational pipelines for RNA-seq data analysis, from QC to sequence alignment and comparative analyses, will reduce analysis time, and increase accuracy and reproducibility of findings to promote transcriptome research.


  • Pregnancy and Takayasu arteritis: case-based review

    by Nirvana Bharuthram, Mohammed Tikly

    Takayasu arteritis (TA) is a rare large vessel vasculitis that particularly affects women of child-bearing age. Management of pregnant patients with TA is often challenging due to the cardiovascular and cerebrovascular complications of the disease. We report two new cases of pregnancy in patients with TA and review all published cases from sub-Saharan Africa. Analysis of 16 pregnancies in 15 patients (including our two cases) showed that seven patients had radiographic Type V TA disease, namely involvement of the entire length of the aorta. Four patients were newly diagnosed with TA during pregnancy and two pregnancies were unbooked at time of first presentation. Seven pregnancies were complicated by disease flares (n = 4) and/or hypertension (n = 6). Four pregnancies resulted in preterm delivery and six required caesarean sections. There was one documented case of pre-eclampsia resulting in the only maternal death. Intrauterine growth restriction was documented in two of six pregnancies in which foetal ultrasonography was performed. There were four low birth weight infants and one fresh stillbirth (associated with the maternal death). In the handful of case reports of pregnancy in TA from sub-Saharan Africa, both maternal and foetal outcomes were generally good and similar to international findings. In a substantial proportion of patients, the diagnosis of TA was made in pregnancy, reflecting challenges of access to appropriate health care in resource constrained sub-Saharan Africa.


  • Open Access

    Tobacco-Derived Lipopolysaccharide, Not Microbial Translocation, as a Potential Contributor to the Pathogenesis of Rheumatoid Arthritis

    by Pieter W. A. Meyer, Mahmood M. T. M. Ally, Mohammed Tikly, Gregory Tintinger, Lai Ling Winchow, Helen Steel, Ronald Anderson

    Microbial lipopolysaccharides (LPS) have been implicated in the pathogenesis of rheumatoid arthritis (RA), possibly driving a systemic inflammatory response that may trigger the development and/or exacerbation of the disease. To explore the existence of this mechanism in African RA patients, we have measured systemic levels of LPS and its surrogate, LPS-binding protein (LBP), as well as those of intestinal fatty acid-binding protein (I-FABP), pulmonary surfactant protein D (SP-D), and cotinine in serum to identify possible origins of LPS, as well as associations of these biomarkers with rheumatoid factor (RF) and anticitrullinated peptide (aCCP) autoantibodies and the DAS 28-3 clinical disease severity score. A cohort of 40 disease-modifying antirheumatic drug-naïve, black South African RA patients rated by compound disease scores and 20 healthy subjects and 10 patients with chronic obstructive pulmonary disease (COPD) as controls were included in this study. Levels of the various biomarkers and autoantibodies were measured using a combination of ELISA and immunofluorimetric and immunoturbidometric procedures. LPS levels were lowest in the RA group compared to the healthy controls (p=0.026) and COPD patients (p=0.017), while LBP levels were also significantly lower in RA compared to the healthy individuals (p=0.036). Levels of I-FABP and SP-D were comparable between all three groups. Categorisation of RA patients according to tobacco usage revealed the following significant positive correlations: LBP with C-reactive protein (p=0.0137); a trend (p=0.073) towards an association of LBP with the DAS 28-3 disease severity score; RF-IgG antibodies with both LPS and LBP (p=0.033 and p=0.041, respectively); aCCP-IgG antibodies with LPS (p=0.044); and aCCP-IgG with RF-IgM autoantibodies (p=0.0016). The findings of this study, several of them novel, imply that tobacco products, as opposed to microbial translocation, represent a potential source of LPS in this study cohort of RA patients, again underscoring the risks posed by tobacco usage for the development and severity of RA.


  • Spectrum of cutaneous lupus erythematosus in South Africans with systemic lupus erythematosus

    by K Koch, M Tikly

    Cutaneous involvement is very common in systemic lupus erythematosus. We describe the prevalence and spectrum of lupus-specific (cutaneous lupus erythematosus) and non-specific cutaneous features amongst mostly black South Africans with systemic lupus erythematosus. A retrospective record review of 298 South Africans (262 blacks and 36 non-blacks) with systemic lupus erythematosus was carried out. Cutaneous features were classified according to the Gilliam and Sontheimer classification of cutaneous lupus. Most (81.5%) patients were black African females. The mean (SD) age at diagnosis and follow-up duration were 35.0 (11.8) and 8.0 (5.9) years, respectively. Cutaneous lupus erythematosus was seen in 76.1% of patients, mainly chronic cutaneous lupus erythematosus with the discoid lupus erythematosus subtype seen in 52.1% of patients. Acute cutaneous lupus erythematosus was seen in 30.2% of patients and was more common in non-blacks than blacks (odds ratio = 3.8 (1.9–7.9)); localized acute cutaneous lupus erythematosus was more common than generalized acute cutaneous lupus erythematosus (odds ratio = 2.6 (1.6–4.4)). Non-specific cutaneous features occurred in 77.2%, with oral/nasal ulcers and Raynaud’s phenomenon each occurring in approximately 40% of patients. Diffuse melanonychia at initial diagnosis was present in 37.4% of patients and was more common in blacks than non-blacks (odds ratio = 3.1 (1.3–7.3)). Acute cutaneous lupus erythematosus was associated with renal disease (odds ratio = 2.8 (1.6–4.7)) and chronic cutaneous lupus erythematosus with arthritis (odds ratio = 2.02 (1.24–3.29)). Diffuse melanonychia was associated with less renal disease and anti-dsDNA antibody positivity (odds ratio = 0.4 (0.3–0.7) and 0.4 (0.2–0.6), respectively) and significantly lower lupus severity index scores (mean (SD) = 5.99 (1.11) vs 6.56 (1.36) in patients with no melanonychia, p < 0.05)). In this study of South Africans with systemic lupus erythematosus, the skin was the most commonly affected organ. In general, cutaneous lupus erythematosus was associated with less severe systemic disease. Acute cutaneous lupus erythematosus was less common in blacks, whereas discoid lupus erythematosus was more common than reported in Caucasians. Diffuse melanonychia was a distinctive finding and was associated with milder systemic disease.


  • Open Access

    Living with systemic lupus erythematosus in South Africa: a bitter pill to swallow

    by A. Phuti, M. Schneider, K. Makan, M. Tikly, B. Hodkinson

    Systemic lupus erythematosus (SLE) often has a profound negative impact on health-related quality of life (HRQoL). In the absence of any qualitative studies in sub-Saharan Africa, we undertook a study to explore living experiences, perceptions and unmet needs of South African patients with SLE. Twenty-five women with SLE consented to participate in the study. They underwent individual in-depth interviews exploring their physical concerns, emotional health, sexual well-being and fertility. NVivo software was used for analysis. Participants were either of black ancestry or mixed racial ancestry, mainly indigent with only a quarter gainfully employed. Living with pain was the most common complaint, negatively impacting on activities of daily living (ADL), family expectations, social life, sleep and intimacy. Most participants expressed challenges of living with fatigue, and many felt their fatigue was misconstrued as being ‘simply lazy’. This pernicious fatigue had negative consequences on many facets of ADL, including caring for dependants, job sustainability and sexual well-being. All participants experienced low emotional states, often associated with suicidal ideations. Many experienced difficulties with fertility and childbearing and these were exacerbated in many instances by the pessimism of health care providers, resulting in confusion and depression. Physical disfigurements resulting from lupus-associated alopecia and rashes and corticosteroid-induced weight fluctuations were a major concern. These changes often affected self-image and libido, leading to strained personal relationships. Coping mechanisms that participants adopted included intense spiritual beliefs, ‘pushing through the difficult times’ and use of alternative therapies to relief symptoms was common. A poor understanding of SLE on the part of participant’s family and the community, coupled with the unpredictable course of the disease, exacerbated frustration and social exclusion. For most, limited income, lack of basic services, family dependencies, and comorbid diseases, such as human immune deficiency virus (HIV), exacerbated the daily negative SLE experiences. In this study of mainly indigent South African women, SLE is associated with complex, chronic and challenging life experiences. The chronic relapsing and unpredictable nature of the disease, poor understanding and acceptance of SLE, compounded by a background of poverty, inadequate social support structures, negatively impact on a range of personal, social and vocational daily life experiences. Improved access to psychosocial services and SLE education might result in better outcomes. (Ethics Project identification code: 275/2016 and M160633 registered 10 & 29 August 2016).